Medical/Pharmaceuticals
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting
TAIPEI, May 23, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of Clinical Oncology (ASCO) Annual Meeting, which ...
2025-05-23 08:00
2510
Cellenkos Inc. and King Faisal Specialist Hospital & Research Centre, Sign Strategic MOU to Advance T Regulatory Cell Therapies for Unmet Diseases
* KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host Disease * Cellenkos to Support Local Cell and Gene Therapy Manufacturing at KFSHRC RIYADH, Saudi Arabia and HOUSTON, May 22, 2025 /PRNewswire/ -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Cellen...
2025-05-22 23:47
2426
Pictor Establishes U.S. Headquarters and Scales Operations, Revolutionizing Proteomics Testing Amid Regulatory Shift
CARLSBAD, Calif., May 22, 2025 /PRNewswire/ -- Pictor, a global leader in multiplex proteomics solutions, is excited to announce the establishment of its U.S. headquarters in Carlsbad, California, marking a significant milestone in its strategic growth and commitment to advancing cutting-edge sol...
2025-05-22 21:42
2451
EdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CRO
Strategic acquisition marks significant step to establish pan-European footprint and deepens expertise in oncology and early-phase biotech clinical trials. LONDON, May 22, 2025 /PRNewswire/ -- Comac Medical Group ("Group"), based in the UK and backed by EdgeCap Partners, announced today the ac...
2025-05-22 20:20
2353
AXA Study: Over 60% of Hong Kong workers encounter elevated stress levels exceeding global average
Younger generation confronts critical mind health challenges, necessitating enhanced workplace support HONG KONG, May 22, 2025 /PRNewswire/ -- Work-related factors exert a greater influence on the mind health of Hong Kong's workforce compared to the global average, according to the latest finding...
2025-05-22 16:55
3688
€2.6 million innovation challenge launches in Southeast Asia to reimagine support for new parents
LONDON, May 22, 2025 /PRNewswire/ -- Smart, public 'parent pods' located in central community spaces such as markets or parks could soon become a reality around the world as a result of the Good Start Challenge: a €2.6 million global challenge launching today with a call for innovations that impr...
2025-05-22 16:00
2863
PROVISION Study Which Met Its Primary Endpoint Now Demonstrates Similar Clinical Outcomes for FFRangio and FFR
PROVISION Study, Prospective Randomized Trial Evaluating Clinical Outcomes of FFRangio Versus FFR Guidance, Demonstrates Similar MACE Rates at One Year PARIS, May 22, 2025 /PRNewswire/ -- Today at the annual EuroPCR conference taking place in Paris, France, Dr. Toru Tanigaki of Gifu Heart Center...
2025-05-22 15:57
2017
JEC Hosts 5th International Ophthalmology Summit, Launches Groundbreaking Digital Eye Health Platform
* Global eye experts reunite in Jakarta for JECIM 2025, after five-year hiatus
* JEC showcases 41 years of ophthalmology leadership and innovation
* Launch of Matapedia marks new chapter in eye health education JAKARTA,
Indonesia, May 22, 2025 /PRNewswire/ -- JEC Eye Hospitals and Clinics
2025-05-22 14:00
2217
Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation
CHENGDU, China, May 22, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new indication application (the "Application") for the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotec...
2025-05-22 10:09
2564
AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients
TAIPEI, May 22, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and rare diseases, today announced positive results from its Phase 1/2a randomized, double-blind, placebo-con...
2025-05-22 09:21
2370
Lethal mutations in pregnancy loss
REYKJAVIK, Iceland, May 21, 2025 /PRNewswire/ -- In a study published in Nature today "Sequence diversity lost in early pregnancy," scientists from deCODE genetics, a subsidiary of Amgen, estimate that around one in 136 pregnancies are lost due to new mutations in the fetus. In other words, milli...
2025-05-21 23:00
2722
Kailo Medical Acquires REI AI to Transform the Future of Radiology Reporting
Strategic acquisition brings generative AI into structured workflows, reinforcing Kailo's mission to deliver long-term impact through trusted, collaborative innovation. MELBOURNE, May 21, 2025 /PRNewswire/ -- Kailo Medical, a global leader in structured reporting for medical imaging, today anno...
2025-05-21 20:38
2139
WHO Foundation and Laerdal Global Health announce US $12.5 million to launch massive Acute Care scale up aiming to save over 50,000 lives per year
Over half of deaths in low-and middle-income countries could be addressed with effective emergency care. GENEVA, May 21, 2025 /PRNewswire/ -- A newly-announced philanthropic partnership between Laerdal Global Health and the WHO Foundation will fund WHO to scale up acute care training for health...
2025-05-21 13:38
2781
Elyon Family Clinic Launches STD Testing Packages Amid Rising Sexual Health Awareness
SINGAPORE, May 21, 2025 /PRNewswire/ -- Elyon Family Clinic & Surgery, an STD
clinic in Singapore
2025-05-21 10:00
1564
PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response
* The first heavily pretreated r/r FL patient dosed at City of Hope with PMB-CT01 achieved a CR at one-month post treatment. * A Total of 7/7 r/r B-NHL patients including MCL, DLBCL and FL treated with PMB-CT01 have achieved a sustained CR (1 to 29+ months) with strictly grade 1 CRS and ICAN...
2025-05-20 22:22
1882
Antengene Enters into a Global Clinical Collaboration with MSD to Evaluate ATG-022 (CLDN18.2 ADC) In Combination with KEYTRUDA® (pembrolizumab)
- ATG-022 is Antengene's CLDN18.2 antibody-drug conjugate; KEYTRUDA® (pembrolizumab) is MSD's anti-PD-1 therapy. SHANGHAI and HONG KONG, May 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical compa...
2025-05-20 20:00
2237
Rockwell Automation Launches EtherNet/IP In-cabinet Solution to Help Manufacturers Build Smarter, More Efficient Panels
New offering can cut wiring time by up to 80%, speeding production and
innovation
MILWAUKEE, Wis., May 20, 2025 /PRNewswire/ -- Rockwell Automation, Inc.
2025-05-20 19:00
2225
Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity
- The combination study is designed to evaluate the safety and preliminary efficacy of a single-dose of ultra-long-acting subcutaneously administered ASC47 in combination with four doses of semaglutide (0.5 mg, once-weekly) in participants with obesity. - Asan adipose-targeted, muscle-preserving...
2025-05-20 18:00
2291
Pulnovo Medical Welcomes EQT as a New Investor Following CE-MDR Approval, with Continued Support from Qiming Venture Partners
HONG KONG, May 20, 2025 /PRNewswire/ -- Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), has received new investment from EQT Group, a top-tier global private equity firm, as a new investor, alongside continued support from ...
2025-05-20 16:53
2574
MediThinQ Enters China Through Strategic Partnership with Sinopharm, Making Wearable Surgical Displays a Reality in Operating Theatres
SINGAPORE, May 20, 2025 /PRNewswire/ -- MediThinQ
2025-05-20 12:50
2898
Week's Top Stories
Most Reposted
Wonder Raises USD 12 Million Venture Debt from HSBC Innovation Banking to Drive Growth and Expansion
[Picked up by 323 media titles]
2026-02-02 10:00
AI adoption is widespread, but developer confidence is still catching up, Agoda report finds
[Picked up by 315 media titles]
2026-02-03 11:00
Mastercard Launches Portfolio of Fleet Solutions in Asia Pacific
[Picked up by 311 media titles]
2026-02-04 09:00Colebrook Bosson Saunders Officially Launches Lana, A Circular Ergonomic Laptop Stand for the Hybrid Generation
[Picked up by 305 media titles]
2026-02-03 12:00
Singapore Airshow 2026 Milestone Edition: 20 Years of Shaping the Aerospace Landscape as Asia-Pacific Drives Global Growth
[Picked up by 288 media titles]
2026-02-01 19:35Most Read
XPENG Announces Vehicle Delivery Results for January 2026
2026-02-01 17:00
5928
DaVinci Gourmet Named Title Sponsor of The World's 100 Best Coffee Shops 2026, to Be Unveiled in Madrid
2026-02-06 21:28
5538
Futu Holdings Wins Five CME Awards, Cementing Industry Leadership in Futures and Options
2026-02-02 10:36
5430
